-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on MiMedx Group, Lowers Price Target to $10

Benzinga·12/17/2025 13:08:56
Listen to the news
Mizuho analyst Anthony Petrone maintains MiMedx Group (NASDAQ:MDXG) with a Outperform and lowers the price target from $12 to $10.